Viewing Study NCT04514393


Ignite Creation Date: 2025-12-25 @ 1:09 AM
Ignite Modification Date: 2025-12-25 @ 11:20 PM
Study NCT ID: NCT04514393
Status: UNKNOWN
Last Update Posted: 2022-04-07
First Post: 2020-08-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
Sponsor: Huiqiang Huang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module